Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab in active rheumatoid arthritis despite methotrexate therapy
2004-003296-36Phase 3Completed
- Sponsor
- Janssen Biotech
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in rheumatoid arthritis (RA), sponsored by Janssen Biotech. Started Nov 2005; status: completed.
02
Drugs
golimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-003296-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003296-36.